Volume 54, Issue 3, Pages (September 2008)

Slides:

Advertisements

Similar presentations

Early Detection of Prostate Cancer in 2007

Advertisements

Volume 56, Issue 5, Pages (November 2009)

Volume 55, Issue 1, Pages 1-8 (January 2009)

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit Pim J. van Leeuwen, David Connolly, Anna.

Volume 70, Issue 3, Pages (September 2016)

Volume 59, Issue 2, Pages (February 2011)

Volume 59, Issue 2, Pages (February 2011)

Volume 57, Issue 1, Pages (January 2010)

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

Volume 51, Issue 2, Pages (February 2007)

Volume 62, Issue 5, Pages (November 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Testosterone Therapy in Men With Prostate Cancer

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Prostate Cancer 2008: Challenges in Diagnosis and Management

Volume 62, Issue 5, Pages (November 2012)

Volume 71, Issue 1, Pages (January 2017)

Volume 68, Issue 5, Pages (November 2015)

Volume 61, Issue 2, Pages (February 2012)

Volume 52, Issue 3, Pages (September 2007)

Prostate Cancer Epidemic in Sight?

Volume 61, Issue 3, Pages (March 2012)

Volume 63, Issue 4, Pages (April 2013)

Volume 66, Issue 1, Pages (July 2014)

Volume 59, Issue 2, Pages (February 2011)

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

Volume 63, Issue 6, Pages (June 2013)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 66, Issue 3, Pages (September 2014)

Volume 66, Issue 6, Pages (December 2014)

Prostate Cancer Epidemic in Sight?

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 2, Pages (August 2014)

Volume 62, Issue 4, Pages (October 2012)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 65, Issue 6, Pages (June 2014)

Tillmann Loch, Pat Fox Fulgham European Urology

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 48, Issue 6, Pages (December 2005)

Volume 64, Issue 4, Pages (October 2013)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 71, Issue 5, Pages (May 2017)

Testicular Cancer Variations in Time and Space in Europe

Volume 53, Issue 1, Pages (January 2008)

Volume 59, Issue 4, Pages (April 2011)

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Prostate Cancer 2008: Challenges in Diagnosis and Management

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Volume 52, Issue 6, Pages (December 2007)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Volume 51, Issue 2, Pages (February 2007)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Does PSA Testing Influence the Natural History of Prostate Cancer?

Volume 52, Issue 5, Pages (November 2007)

Volume 51, Issue 5, Pages (May 2007)

Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood Jan F.M. Verbeek,

Presentation transcript:

Volume 54, Issue 3, Pages 581-588 (September 2008) The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam Claartje Gosselaar, Monique J. Roobol, Stijn Roemeling, Fritz H. Schröder European Urology Volume 54, Issue 3, Pages 581-588 (September 2008) DOI: 10.1016/j.eururo.2008.03.104 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 Flow charts. Number of men screened and biopsied and number of cancers detected and their Gleason scores are displayed for screens 1, 2, and 3. European Urology 2008 54, 581-588DOI: (10.1016/j.eururo.2008.03.104) Copyright © 2008 European Association of Urology Terms and Conditions